康泰医学(300869.SZ)：2025年中报净利润为1693.76万元

Core Insights - 康泰医学 reported a total revenue of 218 million yuan for the first half of 2025, ranking 83rd among disclosed peers [1] - The company's net profit attributable to shareholders was 16.94 million yuan, ranking 76th among disclosed peers [1] - Operating cash flow was 25.90 million yuan, ranking 72nd among disclosed peers [1] Financial Performance - The latest debt-to-asset ratio is 35.93%, ranking 94th among disclosed peers, with an increase of 3.16 percentage points from the previous quarter and 4.10 percentage points from the same period last year [1] - The latest gross profit margin is 60.42% [1] - The latest return on equity (ROE) is 0.95%, ranking 84th among disclosed peers [1] Earnings and Ratios - The diluted earnings per share is 0.04 yuan, ranking 91st among disclosed peers [2] - The total asset turnover ratio is 0.08 times, ranking 104th among disclosed peers [2] - The inventory turnover ratio is 0.31 times, ranking 113th among disclosed peers [2] Shareholder Structure - The number of shareholders is 31,100, with the top ten shareholders holding 238 million shares, accounting for 59.35% of the total share capital [2] - The largest shareholder, 胡坤, holds 43.85% of the shares [2] - Other significant shareholders include 壬桂丽 (11.73%) and 香港中央结算有限公司 (0.93%) [2]